A randomized placebo-controlled trial of adefovir dipivoxil in advanced HIV infection: the ADHOC trial.
OBJECTIVES: To assess the efficacy and safety of adefovir dipivoxil (ADV) added to stable background antiretroviral therapy (ART) in HIV-infected individuals with advanced HIV disease. METHODS: ADHOC was a randomized, double-blind, placebo-controlled, international multicentre trial. Three hundred...
Yazar: | ADHOC International Steering Committee |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2002
|
Benzer Materyaller
-
Adefovir dipivoxil induces DNA replication stress and augments ATR inhibitor-related cytotoxicity
Yazar:: Patel, A, ve diğerleri
Baskı/Yayın Bilgisi: (2020) -
Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial.
Yazar:: Walson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008) -
Moderate to severe HIV-associated neurocognitive impairment: A randomized placebo-controlled trial of lithium
Yazar:: Decloedt, E, ve diğerleri
Baskı/Yayın Bilgisi: (2016) -
What's in placebos: who knows? Analysis of randomized, controlled trials.
Yazar:: Golomb, B, ve diğerleri
Baskı/Yayın Bilgisi: (2010) -
Optimizing the design of invasive placebo interventions in randomized controlled trials
Yazar:: Cousins, S, ve diğerleri
Baskı/Yayın Bilgisi: (2020)